Publications by authors named "Kaz Groen"

Claim this Profile
I
Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial.
Charlotte L B M Korst, Wouter Plattel, Elizabeth A de Kort, Febe Smits, Alexandra J Croockewit, Kaz Groen

Lancet Haematol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.
Wassilis S C Bruins, Febe Smits, Carolien Duetz, Kaz Groen, Charlotte L B M Korst

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frail subgroups determine heterogeneous outcomes in older patients with NDMM: long-term follow-up of the HOVON 143 trial.
Febe Smits, Kaz Groen, Mark-David Levin, Claudia A M Stege, Roel van Kampen

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.
Charlotte L B M Korst, Sabrin Tahri, Carolien Duetz, Wassilis S C Bruins, A Vera de Jonge, Kaz Groen

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma.
Febe Smits, Kaz Groen, Mark-David Levin, Claudia A M Stege, Roel van Kampen

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing.
Charlotte L B M Korst, Kaz Groen, Patricia W C Bosman, Fleur van der Valk, Christie P M Verkleij

Hemasphere· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
Kristine A Frerichs, Christie P M Verkleij, Maria Victoria Mateos, Thomas G Martin, Cesar Rodriguez, Kaz Groen

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correctly structured problem lists lead to better and faster clinical decision-making in electronic health records compared to non-curated problem lists: A single-blinded crossover randomized controlled trial.
Eva S Klappe, Jarom Heijmans, Kaz Groen, Judith Ter Schure, Ronald Cornet

Int J Med Inform· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
Kaz Groen, Claudia A M Stege, Kazem Nasserinejad, Koen de Heer, Roel J W van Kampen

EClinicalMedicine· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
Sabine Haggenburg, Quincy Hofsink, Birgit I Lissenberg-Witte, Annoek E C Broers, Jaap A van Doesum, Kaz Groen

JAMA Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands: a population-based study.
Mirian Brink, Kaz Groen, Pieter Sonneveld, Monique C Minnema, Annemiek Broijl

Blood Cancer J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma.
Maarten R Seefat, David G J Cucchi, Stijn Dirven, Kaz Groen, Sonja Zweegman

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the identification of frail elderly newly diagnosed multiple myeloma patients.
Claudia A M Stege, Kazem Nasserinejad, Saskia K Klein, Gert-Jan Timmers, Mels Hoogendoorn, Kaz Groen

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trauma and psychotic symptoms: data from a pediatric mental health inpatient unit.
Cassandra Hainsworth, Jean Starling, Fernande Brand, Kaz Groen, Karen Munro

J Trauma Stress· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis